This inventor holds 122 USPTO granted patents and 59 published patent applications, plus 12 CIPO patents and 21 EPO patents, primarily in Biocompatible Materials (CPC class A61K35-39). Top assignees: Massachusetts Institute of Technology, Children's Medical Center Corporation, Living Proof, Inc.. Active years: 2006-2026.
Inventors with similar research interests:
Location History:
- San Angelo, TX (US) (2014 - 2017)
- Sudbiry, MA (US) (2018)
- Sudbury, MA (US) (2010 - 2020)
- Farmingham, MA (US) (2020)
- Framington, MA (US) (2020)
- Framingham, MA (US) (2006 - 2024)
- Cambridge, MA (US) (2017 - 2024)
Company Filing History:
103 out of 8,568 
24 out of 1,071 
13 out of 49 
Years Active: 2006-2026
Areas of Expertise:
Daniel Griffith Anderson: A Leading Innovator in Polymer-Lipids and Compositions
Meet Daniel Griffith Anderson, a renowned inventor and researcher in the field of polymer-lipids and compositions, hailing from Framingham, MA. Anderson has made significant contributions to the field of medical science through his remarkable work in the development of innovative technologies and patents for the delivery of therapeutic agents such as nucleic acids to the target cells.
Anderson's illustrious career has spanned several years, having worked with renowned organizations like Massachusetts Institute of Technology and Children's Medical Center Corporation. He has set an exemplary record in the number of patents he has obtained, which is a whopping 94 patents.
Recently, Anderson has made significant strides in improving the selection and formulation of PBAE polymers. In one of his latest patents, Anderson has developed a design of experiment approach, which uses statistical methods for limiting the possible experimental conditions. This method has proved to be a game-changer and has led to the development of improved PBAE polymers and formulations that offer better drug-delivery features.
Additionally, Anderson's patent in poly (beta-amino esters) and uses thereof has gained a lot of attention. The branched poly (beta-amino esters) (PBAE) is useful as a delivery vehicle for therapeutic agents and has shown promising results in delivering therapeutic agents such as mRNA to lung epithelial cells.
Anderson has worked with exceptional co-workers like Robert S Langer and Arturo Jose Vegas, who are well-known in the field of medical science for their groundbreaking research and contributions.
In conclusion, Daniel Griffith Anderson's contributions to the field of polymer-lipids and compositions have been immense. His inventions have impacted the field of drug delivery and have the potential to revolutionize the healthcare industry. With continued research and development, Anderson and his team may just be uncovering the tip of the iceberg with the potential applications of their patents.